DGI:ZNS-Infektionen/Nosokomiale Ventrikulitis und Meningitis/Quellen - Revision history

imported>Bestem at 16:22, 9 September 2021

2021-09-09T16:22:03Z

← Older revision		Revision as of 16:22, 9 September 2021
Line 1:		Line 1:
	28. <span class="ve-pasteProtect" data-ve-attributes="{"style":"~~mso~~-~~tab-count~~:1"}" style="box-sizing: inherit;"> <span> </span></span>Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR: 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017; 64: e34–e65		# <span class="ve-pasteProtect" data-ve-attributes="{"style":"box-sizing: inherit;"}" style="box-sizing: inherit;">Ambulant erworbene bakterielle (eitrige) Meningoenzephalitis im Erwachsenenalter, AWMF-Registernummer: 030/089 [</span>https://www.awmf.org/leitlinien/detail/ll/030-089.html<span class="ve-pasteProtect" data-ve-attributes="{"style":"box-sizing: inherit;"}" style="box-sizing: inherit;">]</span>
			# Beer R, Lackner P, Pfausler B, Schmutzhard E: Nosocomial ventriculitis and meningitis in neurocritical care patients. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-ansi-language:DE"}" style="box-sizing: inherit;">J Neurol 2008; 255(11):1617-1624</span>
			# Karvouniaris M, Brotis AG, Tsiamalou P, Fountas KN: The Role of Intraventricular Antibiotics in the Treatment of Nosocomial Ventriculitis/Meningitis from Gram-Negative Pathogens: A Systematic Review and Meta-Analysis. World Neurosurg 2018; 120:e637-e650
			# Mader MM, Czorlich P, Konig C, Fuhrmann V, Kluge S, Westphal M, Grensemann J: Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis. Acta Neurochir (Wien) 2018; 160(11):2099-2105
			# Nau R, Seele J, Djukic M, Eiffert H: Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections. Curr Opin Infect Dis 2018; 31(1):57-68
			# Nau R, Blei C, Eiffert H: Intrathecal Antibacterial and Antifungal Therapies. Clin Microbiol Rev 2020; 33(3)
			# Nau R, Sorgel F, Eiffert H: Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010; 23(4):858-883
			# Nau R, Sorgel F, Prange HW: Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998; 35(3):223-246
			# Reyes MM, Munigala S, Church EL, Kulik TB, Keyrouz SG, Zipfel GJ, Warren DK: Comparing External Ventricular Drains-Related Ventriculitis Surveillance Definitions. Infect Control Hosp Epidemiol 2017; 38(5):574-579
			# Tangden T, Enblad P, Ullberg M, Sjolin J: Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis 2011; 52(11):1310-1316
			# Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR: 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017; 64: e34–e65

	29. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Reyes MM, Munigala S, Church EL, Kulik TB, Keyrouz SG, Zipfel GJ, Warren DK: Comparing External Ventricular Drains-Related Ventriculitis Surveillance Definitions. Infect Control Hosp Epidemiol 2017; 38(5):574-579

	30. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Beer R, Lackner P, Pfausler B, Schmutzhard E: Nosocomial ventriculitis and meningitis in neurocritical care patients. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-ansi-language:DE"}" style="box-sizing: inherit;">J Neurol 2008; 255(11):1617-1624</span>

	<span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-ansi-language:\nDE"}" style="box-sizing: inherit;">31. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Ambulant erworbene bakterielle (eitrige) Meningoenzephalitis im Erwachsenenalter, AWMF-Registernummer: 030/089 [</span>https://www.awmf.org/leitlinien/detail/ll/030-089.html<span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-ansi-language:DE"}" style="box-sizing: inherit;">]</span>

	32. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Nau R, Blei C, Eiffert H: Intrathecal Antibacterial and Antifungal Therapies. Clin Microbiol Rev 2020; 33(3)

	33. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Karvouniaris M, Brotis AG, Tsiamalou P, Fountas KN: The Role of Intraventricular Antibiotics in the Treatment of Nosocomial Ventriculitis/Meningitis from Gram-Negative Pathogens: A Systematic Review and Meta-Analysis. World Neurosurg 2018; 120:e637-e650

	34. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Nau R, Seele J, Djukic M, Eiffert H: Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections. Curr Opin Infect Dis 2018; 31(1):57-68

	35. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Nau R, Sorgel F, Eiffert H: Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010; 23(4):858-883

	36. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Nau R, Sorgel F, Prange HW: Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998; 35(3):223-246

	37. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Mader MM, Czorlich P, Konig C, Fuhrmann V, Kluge S, Westphal M, Grensemann J: Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis. Acta Neurochir (Wien) 2018; 160(11):2099-2105

	38. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Tangden T, Enblad P, Ullberg M, Sjolin J: Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis 2011; 52(11):1310-1316
	<br />		<br />

imported>Fuhrmanns at 19:46, 9 August 2021

2021-08-09T19:46:57Z

← Older revision		Revision as of 19:46, 9 August 2021
Line 1:		Line 1:
	~~== Quellen ==~~
	28. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR: 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017; 64: e34–e65		28. <span class="ve-pasteProtect" data-ve-attributes="{"style":"mso-tab-count:1"}" style="box-sizing: inherit;"> <span> </span></span>Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR: 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017; 64: e34–e65

imported>Maximilian.schons@uk-koeln.de: Maximilian.schons@uk-koeln.de verschob die Seite DGI:Nosokomiale Ventrikulitis und Meningitis/Quellen nach DGI:ZNS-Infektionen/Nosokomiale Ventrikulitis und Meningitis/Quellen: Textersetzung - „Nosokomiale Ventrikulitis und Meningitis“ durc…

2021-08-03T07:40:03Z

Maximilian.schons@uk-koeln.de verschob die Seite DGI:Nosokomiale Ventrikulitis und Meningitis/Quellen nach DGI:ZNS-Infektionen/Nosokomiale Ventrikulitis und Meningitis/Quellen: Textersetzung - „Nosokomiale Ventrikulitis und Meningitis“ durc…

← Older revision	Revision as of 07:40, 3 August 2021
(No difference)

imported>Brinkery: Die Seite wurde neu angelegt: „== Quellen == 28. …“

2020-12-14T22:57:14Z

Die Seite wurde neu angelegt: „== Quellen == 28. …“

New page

== Quellen ==
28. Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR: 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017; 64: e34–e65

29. Reyes MM, Munigala S, Church EL, Kulik TB, Keyrouz SG, Zipfel GJ, Warren DK: Comparing External Ventricular Drains-Related Ventriculitis Surveillance Definitions. Infect Control Hosp Epidemiol 2017; 38(5):574-579

30. Beer R, Lackner P, Pfausler B, Schmutzhard E: Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol 2008; 255(11):1617-1624

31. Ambulant erworbene bakterielle (eitrige) Meningoenzephalitis im Erwachsenenalter, AWMF-Registernummer: 030/089 [https://www.awmf.org/leitlinien/detail/ll/030-089.html]

32. Nau R, Blei C, Eiffert H: Intrathecal Antibacterial and Antifungal Therapies. Clin Microbiol Rev 2020; 33(3)

33. Karvouniaris M, Brotis AG, Tsiamalou P, Fountas KN: The Role of Intraventricular Antibiotics in the Treatment of Nosocomial Ventriculitis/Meningitis from Gram-Negative Pathogens: A Systematic Review and Meta-Analysis. World Neurosurg 2018; 120:e637-e650

34. Nau R, Seele J, Djukic M, Eiffert H: Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections. Curr Opin Infect Dis 2018; 31(1):57-68

35. Nau R, Sorgel F, Eiffert H: Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010; 23(4):858-883

36. Nau R, Sorgel F, Prange HW: Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998; 35(3):223-246

37. Mader MM, Czorlich P, Konig C, Fuhrmann V, Kluge S, Westphal M, Grensemann J: Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis. Acta Neurochir (Wien) 2018; 160(11):2099-2105

38. Tangden T, Enblad P, Ullberg M, Sjolin J: Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis 2011; 52(11):1310-1316